Results 261 to 270 of about 61,893 (290)
Some of the next articles are maybe not open access.

A review of current and promising nontuberculous mycobacteria antibiotics.

Future Medicinal Chemistry, 2021
Nontuberculous mycobacteria infections are a growing concern, and their incidence has been increasing worldwide in recent years. Current treatments are not necessarily useful because many were initially designed to work against other bacteria, such as ...
Christophe Cantelli   +2 more
semanticscholar   +1 more source

Nontuberculous mycobacteria

Current Opinion in Pulmonary Medicine, 1997
The nontuberculous mycobacteria (NTM), especially Mycobacterium avium complex, are being recognized with increasing frequency as clinical pathogens, not only as a cause of disseminated disease in patients with AIDS but also as a cause of chronic lung disease in patients without AIDS. These infections have traditionally been difficult and frustrating to
openaire   +2 more sources

Nontuberculous Mycobacteria

The American Journal of the Medical Sciences, 2001
The nontuberculous mycobacteria are for the most part ubiquitous environmental organisms that only rarely cause disease in humans. Therefore, the normal host defense against these organisms must be quite robust, as exposure is universal and disease is rare.
openaire   +2 more sources

Lung infection with nontuberculous mycobacteria

Radiología (English Edition), 2023
To describe the epidemiology and CT findings for nontuberculous mycobacterial lung infections and outcomes depending on the treatment.We retrospectively studied 131 consecutive patients with positive cultures for nontuberculous mycobacteria between 2005 and 2016. We selected those who met the criteria for nontuberculous mycobacterial lung infection. We
C, Cano Rodríguez   +6 more
openaire   +2 more sources

Outbreaks of nontuberculous mycobacteria

Current Opinion in Infectious Diseases, 2017
Purpose of reviewThe purpose of this review is to summarize the emerging literature on nontuberculous mycobacteria outbreaks in healthcare settings. As our ability to identify mycobacterial species develops, we are better able to recognize epidemiologic connections and better understand the prevalence and importance of these outbreaks and pseudo ...
Geeta, Sood, Nikki, Parrish
openaire   +2 more sources

Nontuberculous mycobacteria.

American family physician, 1984
Nontuberculous mycobacteria are identified in almost half of the cultures reported positive for mycobacteria in clinical laboratories in the United States. While many represent saprophytic colonization or laboratory contamination, a significant number of these organisms are the agents of disease.
C B, Hartley, H, Yeager
openaire   +1 more source

Nontuberculous mycobacteria in cystic fibrosis

Infectious Disease Clinics of North America, 2002
The incidence of NTM pulmonary infections increasingly is recognized in patients with CF. This may reflect the increasing longevity of this population with increased environmental exposure time, a high index of suspicion, and/or some as of yet unidentified predisposing factor(s). The most common species of NTM in CF is MAC, followed by M.
Deborah L, Ebert, Kenneth N, Olivier
openaire   +2 more sources

Pathogenesis of nontuberculous mycobacteria infections

Clinics in Chest Medicine, 2002
M avium is a microorganism well adapted to living in the environment and in different hosts. During the past 15 years, a substantial amount of information has been accumulated about the mechanisms used by M avium to cross the host's mucosal barrier, replicate inside cells, circumvent the host's immune response, and persist inside the host. It turns out
Jeffery, McGarvey, Luiz E, Bermudez
openaire   +2 more sources

Laboratory diagnosis of nontuberculous mycobacteria

Clinics in Chest Medicine, 2002
In conclusion, it is important to realize that there is no "stand alone" assay for the identification of NTM. Many new species may not be recognized in all assays. Newer molecular tests are more accurate for identification than phenotypic tests and have significantly improved turnaround time.
Akos, Somoskovi   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy